by continuing to use this site you consent to the use of cookies on your device as described in our . . . .
here are 4 mass. biotechs making noise at the ash conference so far .
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. . .